Issue Briefs

Issue Brief 9 - Colorectal Cancer Screening: The Genetic Factor

Wednesday, October 8, 2014

 

Issue Brief 9 thumbnailColorectal Cancer Screening: The Genetic Factor ( HTML | PDF  )

Colorectal cancer is the second leading cause of cancer deaths in the United States. Thankfully, it is also one of the most treatable and curable cancers, if detected early. Unfortunately, a high percentage of late stage colorectal cancers are fatal, with the American Cancer Society citing a five year survival rate of Stage IV cancers as low as only 6%. While preventative screening colonoscopies can go a long way in helping to catch cancerous polyps early and save lives, new medical developments in the field of genetic testing can help take colorectal cancer prevention to a new level.

 

 

Issue Brief 8 - Drug Shortages Impact Colorectal Cancer

Tuesday, October 7, 2014

 

Issue Brief 8 thumbnailDrug Shortages Impact Colorectal Cancer ( HTML | PDF  )

Over the past several years, drug shortages have become an increasingly severe problem for those working throughout the health care industry, as well as for patients who depend on pharmaceuticals every day. Drug shortages are not new, but now hospitals and physicians are having more difficulty finding adequate supplies of drugs to meet the needs of their patients. Some of the drugs that have seen supply problems are those used in colorectal cancer screenings. If we realize the mission of dramatically increasing screening rates among Americans, drug shortages could prove to become an even bigger issue than it is today.

 

Issue Brief 7 - Take Advantage of the Patient Protection and Affordable Care Act Preventive Care Clause

Monday, May 19, 2014

 

Issue Brief 7 thumbnailTake Advantage of the Patient Protection and Affordable Care Act Preventive Care Clause ( HTML | PDF  )

Considering one in 20 Americans will develop colorectal cancer at some point in their lives, colorectal cancer screenings are vitally important as a preventative measure. Because colorectal cancer is the second leading cause of cancer deaths in the United States, screenings have never been more important. Fortunately, the Patient Protection and Affordable Care Act (PPACA), which passed Congress in 2010, has markedly improved access to screenings.

 

Issue Brief 6 - FDA Approves SEDASYS Device

Thursday, October 3, 2013

 

FDA Approves SEDASYS Device ( HTML | PDF  )

In recent years, Ethicon Endo-Surgery, Inc., a Johnson & Johnson subsidiary, has developed a Computer-Assisted Personalized Sedation (CAPS) product called SEDASYS, which administers a sedative (propofol) to patients undergoing certain procedures, including colonoscopies. On May 3, 2013, the U.S. Food and Drug Administration (FDA) approved the use of this device in limited medical cases after it was originally denied by the agency in April 2010. SEDASYS deployment and use is expected to begin in 2014.

 

Issue Brief 5 - The Impact of Health Insurance Reform on Colorectal Cancer

Monday, June 10, 2013

 

The Impact of Health Insurance Reform on Colorectal Cancer ( HTML | PDF )

Preventing Colorectal Cancer, a not-for-profit oganization, encourages policymakers, health officials, health plan executives and others to support colonoscopies as the gold standard colorectal cancer screening method. Health insurance reform has significantly changed the level of access that many Americans have to colorectal cancer screening. This issue brief is one in a series of publications describing what actions we can take together to make a difference and help patients navigate the waters of recent health insurance reform.

 

Pages